Cover Image
市場調查報告書

全球學名藥市場:各國市場

World Generic Market Report 2015 - Volume II: National Markets

出版商 Espicom Business Intelligence 商品編碼 316059
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
全球學名藥市場:各國市場 World Generic Market Report 2015 - Volume II: National Markets
出版日期: 2015年03月31日 內容資訊: 英文
簡介

全球學名藥市場外部及產業特有的風險因素越來越暴露出來。作為經濟復甦的一端,醫療保健的成本控制鎖定學名藥支出,同時學名藥廠商和廠商的投資家,躊躇於貨幣變動。

本報告提供全球學名藥市場趨勢之各國調查分析。

BMI的產業預測

產業預測

  • 非洲
    • 學名藥市場指標、過去的資料及預測
  • 阿爾及利亞
  • 埃及
  • 迦納
  • 肯亞
  • 摩洛哥
  • 奈及利亞
  • 南非
  • 辛巴威
  • 亞太地區
  • 澳洲
  • 孟加拉國
  • 中國
  • 香港
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 紐西蘭
  • 巴基斯坦
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南
  • 歐洲
  • 奧地利
  • 白俄羅斯
  • 比利時
  • 保加利亞
  • 克羅埃西亞
  • 捷克
  • 愛沙尼亞
  • 芬蘭
  • 法國
  • 德國
  • 希臘
  • 匈牙利
  • 義大利
  • 哈薩克
  • 拉脫維亞
  • 立陶宛
  • 摩爾多瓦
  • 荷蘭
  • 波蘭
  • 葡萄牙
  • 羅馬尼亞
  • 俄羅斯
  • 塞爾維亞
  • 斯洛伐克
  • 斯洛維尼亞
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 英國
  • 烏克蘭
  • 烏茲別克
  • 南美
  • 阿根廷
  • 巴西
  • 智利
  • 哥倫比亞
  • 墨西哥
  • 秘魯
  • 波多黎各
  • 委內瑞拉
  • 中東
  • 巴林
  • 伊朗
  • 以色列
  • 約旦
  • 科威特
  • 黎巴嫩
  • 阿曼
  • 卡達
  • 沙烏地阿拉伯
  • UAE
  • 北美
  • 加拿大
  • 美國

詞彙表

調查手法

目錄

Now in its 13th edition the World Generic Market Report presents a detailed picture of the nature and state of the world market for generic pharmaceuticals.

Although the global generic drug market will almost double in size over the next decade, there will be consistent pressure on realisable profit margins for manufacturers as governments will increasingly favour commodity generics over branded products. Bulk purchasing by payers in the form of tenders results in high volume sales, but at lower prices. A more competitive operating environment will also drive down prices.

The generic drug business is highly competitive and successfully operating in this industry will require an understanding of what the best generic drug opportunities are now and in the future. An insight into growth markets and their operating environments is essential, and knowledge of the major players will add a competitive edge. Espicom has produced a number of highly regarded reports on this Industry along with subscription products which constantly evaluate an ever changing picture.

Global generic drug markets are increasingly subject to external and industry-specific risk factors. As part of the economic recovery, cost containment in healthcare has targeted spending on generic drugs, while generic manufacturers and their investors are often surprised by currency fluctuations. Negative perceptions of generic drugs' quality persist, but attitudes are changing. Thanks to efforts to rationalise prescribing and dispensing, generic drug substitution is becoming more common.

With coverage of over 76 key markets across 6 regions the World Generic Market Report 2015 -- Volume II: National Markets report is a must have resource for anyone operating in the generics industry.

The World Generic Market Report 2015 -- Volume II: National Markets brings together a range of often difficult to source information in one single, convenient and comprehensive publication.

Table of Contents

BMI Industry View

Industry Forecast

  • Africa
  • Algeria
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Algeria 2011-2019)
  • Egypt
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
  • Ghana
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ghana 2011-2019)
  • Kenya
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kenya 2011-2019)
  • Morocco
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
  • Nigeria
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Nigeria 2011-2019)
  • South Africa
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (South Africa 2011-2019)
  • Zimbabwe
  • Asia Pacific
  • Australia
    • Table: Cost Of Selected Drugs Post-Price Disclosure, April 2013
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Australia 2011-2019)
  • Bangladesh
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2011-2019)
  • China
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (China 2011-2019)
  • Hong Kong
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019)
  • India
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (India 2011-2019)
  • Indonesia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Indonesia 2011-2019)
  • Japan
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Japan 2011-2019)
  • Malaysia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019)
  • New Zealand
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (New Zealand 2011-2019)
  • Pakistan
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Pakistan 2011-2019)
  • Philippines
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
  • Singapore
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Singapore 2011-2019)
  • South Korea
    • Structural Trends
      • Table: Generic Drug Market Indicators, Historical Data And Forecasts (South Korea 2011-2019)
  • Taiwan
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Taiwan 2011-2019)
  • Thailand
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Thailand 2011-2019)
  • Vietnam
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019)
  • Europe
  • Austria
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Austria 2011-2019)
  • Belarus
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
  • Belgium
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belgium 2011-2019)
  • Bulgaria
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019)
  • Croatia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Croatia 2011-2019)
  • Czech Republic
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2011-2019)
  • Estonia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)
  • Finland
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2011-2019)
  • France
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (France 2011-2019)
  • Germany
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Germany 2011-2019)
  • Greece
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Greece 2011-2019)
  • Hungary
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)
  • Italy
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Italy 2011-2019)
  • Kazakhstan
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)
  • Latvia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Latvia 2011-2019)
  • Lithuania
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lithuania 2011-2019)
  • Moldova
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Moldova 2011-2019)
  • Netherlands
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019)
  • Poland
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Poland 2011-2019)
  • Portugal
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Portugal 2011-2019)
    • Table: Top Generic Drugs By Value In 2011
    • Table: Average Price Of Top Generic Drugs By Value 2010-2011
  • Romania
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Romania 2011-2019)
  • Russia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2011-2019)
  • Serbia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Serbia 2011-2019)
  • Slovakia
    • Table: Members Of GENAS, 2015
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovakia 2011-2019)
  • Slovenia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019)
  • Spain
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Spain 2011-2019)
  • Sweden
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Sweden 2011-2019)
  • Switzerland
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019)
  • Turkey
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Turkey 2011-2019)
  • Ukraine
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ukraine 2011-2019)
  • United Kingdom
  • Uzbekistan
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019)
  • Latin America
  • Argentina
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Argentina 2011-2019)
  • Brazil
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Brazil 2011-2019)
  • Chile
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Chile 2011-2019)
  • Colombia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019)
  • Mexico
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019)
  • Peru
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Peru 2011-2019)
  • Puerto Rico
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019)
  • Venezuela
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019)
  • Middle East
  • Bahrain
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bahrain 2011-2019)
  • Iran
  • Israel
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Israel 2011-2019)
  • Jordan
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
  • Kuwait
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
  • Lebanon
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
  • Oman
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2013-2019)
  • Qatar
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Qatar 2011-2019)
  • Saudi Arabia
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019)
  • UAE
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)
  • North America
  • Canada
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Canada 2011-2019)
  • United States
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (United States 2011-2019)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top